Minnesota's New Prescription Drug Price Transparency Reporting: What You Need to Know | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | In recent years, the transparency surrounding prescription drug pricing has become a focal point for...
BLOG
Nevada Levies $17.4 Million in Fines on Diabetes Drug Manufacturers
The State of Nevada shocked the pharmaceutical supply chain last month by levying an unprecedented $17.4 million in fines due to deficient reporting by drug manufacturers of prescription drugs that are essential for treating diabetes in Nevada.
Iowa Board of Pharmacy Approves NCDQS QAS Accreditation as Part of Waiver to VAWD Requirement
In 2018, legislation was passed in Iowa that required a company to have VAWD Accreditation as a prerequisite to being awarded wholesale drug distribution licensing, in line with three other states.
Puerto Rico’s Regulation of the Drug Supply Chain: Past, Present and Future
Puerto Rico became a U.S. territory over 100 years ago after the conclusion of the Spanish-American War. As a territory that is still citing laws passed as early as 1912 to regulate the pharmaceutical supply chain, there are many nuances to ensuring compliance when doing business on the island.
New York Opioid Tax & Minnesota Regulatory Fee Changes
New York Opioid Tax & Minnesota Regulatory Fee Changes As the changes to state laws per DSCSA continues to sweep the country, the Opioid...
Sumeet Singh Completes the Goldman Sachs 10,000 Small Businesses Program
What the OptumRx Litigation Means to Industry We have received a lot of questions over the past few weeks on how the lawsuit is progressing and what...
PBMs & Pharmacies, Episode V: States Strike Back
PBMs & Pharmacies, Episode V: States Strike Back The State of New York recently passed into law Assembly Bill A9507C, a seemingly mundane bill...